Cargando…
The Very Low IgE Producer: Allergology, Genetics, Immunodeficiencies, and Oncology
Opposite to other immunoglobulin (Ig) classes and subclasses, there is no consensus on the definition of normal levels of serum total IgE. However, longitudinal studies on birth cohorts produced growth charts of total IgE levels in helminth-free and never atopic children and defining the normal rang...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10216455/ https://www.ncbi.nlm.nih.gov/pubmed/37239049 http://dx.doi.org/10.3390/biomedicines11051378 |
_version_ | 1785048302351286272 |
---|---|
author | Matricardi, Paolo Maria |
author_facet | Matricardi, Paolo Maria |
author_sort | Matricardi, Paolo Maria |
collection | PubMed |
description | Opposite to other immunoglobulin (Ig) classes and subclasses, there is no consensus on the definition of normal levels of serum total IgE. However, longitudinal studies on birth cohorts produced growth charts of total IgE levels in helminth-free and never atopic children and defining the normal ranges of total serum IgE concentration at the individual, rather than population, level. Accordingly, very ‘low IgE producers’ (i.e., children whose tIgE level belong to the lowest percentiles) became atopic while keeping their total IgE levels in a range considered ‘normal’ if compared to the general age-matched population but ‘abnormally high’ if projected on the tIgE growth chart against the trajectory of that child’s own percentile levels. In ‘low IgE producers’, the IgE-specific activity, i.e., the ratio between allergen-specific and total IgE, is more important than the absolute specific IgE levels to confirm causality between allergen exposure and allergic symptoms. Patients with allergic rhinitis or peanut anaphylaxis but low or undetectable allergen-specific IgE levels must therefore be reconsidered considering their total IgE levels. Low IgE producers have been also associated with common variable immunodeficiency, lung diseases, and malignancies. A few epidemiological studies have shown a higher risk of malignancies in very low IgE producers, leading to a debated hypothesis proposing a novel, evolutionistic-relevant function for IgE antibodies for antitumor immune surveillance. |
format | Online Article Text |
id | pubmed-10216455 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-102164552023-05-27 The Very Low IgE Producer: Allergology, Genetics, Immunodeficiencies, and Oncology Matricardi, Paolo Maria Biomedicines Review Opposite to other immunoglobulin (Ig) classes and subclasses, there is no consensus on the definition of normal levels of serum total IgE. However, longitudinal studies on birth cohorts produced growth charts of total IgE levels in helminth-free and never atopic children and defining the normal ranges of total serum IgE concentration at the individual, rather than population, level. Accordingly, very ‘low IgE producers’ (i.e., children whose tIgE level belong to the lowest percentiles) became atopic while keeping their total IgE levels in a range considered ‘normal’ if compared to the general age-matched population but ‘abnormally high’ if projected on the tIgE growth chart against the trajectory of that child’s own percentile levels. In ‘low IgE producers’, the IgE-specific activity, i.e., the ratio between allergen-specific and total IgE, is more important than the absolute specific IgE levels to confirm causality between allergen exposure and allergic symptoms. Patients with allergic rhinitis or peanut anaphylaxis but low or undetectable allergen-specific IgE levels must therefore be reconsidered considering their total IgE levels. Low IgE producers have been also associated with common variable immunodeficiency, lung diseases, and malignancies. A few epidemiological studies have shown a higher risk of malignancies in very low IgE producers, leading to a debated hypothesis proposing a novel, evolutionistic-relevant function for IgE antibodies for antitumor immune surveillance. MDPI 2023-05-06 /pmc/articles/PMC10216455/ /pubmed/37239049 http://dx.doi.org/10.3390/biomedicines11051378 Text en © 2023 by the author. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Matricardi, Paolo Maria The Very Low IgE Producer: Allergology, Genetics, Immunodeficiencies, and Oncology |
title | The Very Low IgE Producer: Allergology, Genetics, Immunodeficiencies, and Oncology |
title_full | The Very Low IgE Producer: Allergology, Genetics, Immunodeficiencies, and Oncology |
title_fullStr | The Very Low IgE Producer: Allergology, Genetics, Immunodeficiencies, and Oncology |
title_full_unstemmed | The Very Low IgE Producer: Allergology, Genetics, Immunodeficiencies, and Oncology |
title_short | The Very Low IgE Producer: Allergology, Genetics, Immunodeficiencies, and Oncology |
title_sort | very low ige producer: allergology, genetics, immunodeficiencies, and oncology |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10216455/ https://www.ncbi.nlm.nih.gov/pubmed/37239049 http://dx.doi.org/10.3390/biomedicines11051378 |
work_keys_str_mv | AT matricardipaolomaria theverylowigeproducerallergologygeneticsimmunodeficienciesandoncology AT matricardipaolomaria verylowigeproducerallergologygeneticsimmunodeficienciesandoncology |